| Literature DB >> 28097522 |
Bernd Hewing1,2,3, Sebastian Chi-Diep Au4,5, Antje Ludwig4,5, Rena Ellerbroek4, Phillip van Dijck4, Lisa Hartmann6,7, Herko Grubitzsch8, Carolin Giannini9, Michael Laule4, Verena Stangl4,5, Gert Baumann4, Karl Stangl4,5.
Abstract
Individual monocyte subsets have been associated with atherosclerotic disease, but their distribution has not been evaluated in aortic valve stenosis (AS) so far. In the present study, we have asked whether levels of the circulating intermediate monocyte subset are increased in AS. Classical (CD14++CD16-), intermediate (CD14++CD16+), and non-classical (CD14+CD16++) CD86-positive monocytes and monocyte activation (intensity of CD11b expression) were determined by flow cytometry in peripheral blood of patients with severe AS (n = 100) and matched AS-free controls (n = 75). AS patients exhibited significantly higher levels of circulating intermediate monocytes, while levels of circulating classical and non-classical monocytes or monocyte activation did not differ compared to controls. The difference in levels of intermediate monocytes between groups was independent of age, gender, BMI, LDL-C, NT-proBNP, NYHA functional class, or creatinine levels. The present pilot study provides evidence of an association of severe AS with increased levels of circulating intermediate monocytes. Further studies need to clarify whether this finding is related to the inflammatory status and hemodynamic disturbances associated with severe AS.Entities:
Keywords: Aortic valve stenosis; Inflammation; Monocyte subsets
Mesh:
Substances:
Year: 2017 PMID: 28097522 DOI: 10.1007/s12265-016-9726-9
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132